Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci
- 1 September 1994
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 344 (8923) , 639-642
- https://doi.org/10.1016/s0140-6736(94)92083-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Group A streptococcal M proteins: virulence factors and protective antigensImmunology Today, 1992
- Protective and autoimmune epitopes of streptococcal M proteinsVaccine, 1988
- Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem.The Journal of Experimental Medicine, 1987
- Resurgence of Acute Rheumatic Fever in the Intermountain Area of the United StatesNew England Journal of Medicine, 1987
- Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein.The Journal of Experimental Medicine, 1986
- Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate.Circulation, 1984
- Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein.The Journal of Experimental Medicine, 1983
- Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M proteinNature, 1981
- Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.The Journal of Experimental Medicine, 1979
- DIFFERENTIATION OF GROUP A STREPTOCOCCI WITH A COMMON R ANTIGEN INTO THREE SEROLOGICAL TYPES, WITH SPECIAL REFERENCE TO THE BACTERICIDAL TESTThe Journal of Experimental Medicine, 1957